Skip to content
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Allergy and Immunology

How Do I Get a Tryptase Blood Test During an MCAS Flare?

At a Glance

To successfully get a tryptase blood test during an MCAS flare, you must have your blood drawn within 1 to 4 hours of symptom onset before levels drop. Prepare by securing a standing lab order from your doctor in advance and having a designated person drive you to a nearby lab.

Navigating the 1 to 4 hour window for a serum tryptase test during a Mast Cell Activation Syndrome (MCAS) flare is one of the most frustrating hurdles patients face. To successfully capture this crucial blood test, the most effective strategy is proactive planning before a flare ever happens. By securing a standing lab order, mapping out local labs, and preparing backup options, you can bypass the delays of scheduling appointments during an active medical event [1][2].

Why the 1-4 Hour Window Matters

When mast cells degranulate (release their chemical contents) during a flare, serum tryptase levels spike rapidly. This spike typically peaks within 1 to 2 hours of symptom onset before steadily declining back to normal [3][4]. Because tryptase clears from the bloodstream quickly, testing too late will show a falsely normal result, missing the evidence of a flare [5][6].

Medical consensus criteria diagnose an MCAS flare by looking for a specific rise in tryptase during an attack compared to your symptom-free baseline level [7][4]. The “20% + 2” formula requires your flare tryptase level to increase by at least 20% over your baseline level, plus an additional 2 ng/mL [8][7].

To make this calculation, your doctor needs two samples: the acute sample (drawn 1 to 4 hours into the flare) and a true baseline sample. The baseline sample must be drawn when you are completely asymptomatic, typically at least 24 to 48 hours after all flare symptoms have entirely resolved [9][8].

Safety First: Severe Flares and Anaphylaxis

If your flare involves signs of anaphylaxis (such as difficulty breathing, swelling of the throat, or a sudden drop in blood pressure), emergency medical treatment always supersedes getting a lab test.

Never delay using epinephrine or calling emergency services just to drive to a lab. If you need to go to the Emergency Room, simply tell the triage nurse or attending doctor upon arrival that you are having a severe mast cell flare and request that they draw an acute serum tryptase level alongside your emergency care [6][10].

Practical Logistics: Preparing for a Flare

Because of the short timeframe, you cannot wait until a flare begins to plan. When you are experiencing racing heart, brain fog, and severe discomfort, managing logistics is nearly impossible. Prepare these steps in advance:

  • Obtain a Standing Order: Ask your physician for a “standing lab order” specifically for an acute serum tryptase test [1][2]. Ask them to explicitly write any necessary lab handling instructions (like “centrifuge promptly”) directly on the order so you do not have to try to supervise the phlebotomist while feeling ill.
  • Scout Your Locations: Identify labs or urgent care centers near your home or workplace. Call them in advance to confirm they can accommodate walk-in “stat” blood draws. Critically, ask if they accept outside standing orders, as some urgent care facilities require you to see their doctor first, which wastes your 1 to 4 hour window.
  • Establish a “Flare Buddy”: Driving with severe tachycardia, dizziness, or gastrointestinal issues is incredibly dangerous. Arrange for a designated friend, family member, or neighbor who knows the plan and can safely drive you to the lab.
  • Understand Sample Handling: While serum tryptase is actually relatively stable compared to other markers [11][12], it is best practice for the lab to centrifuge (spin down) the blood and refrigerate or freeze the separated serum if processing is delayed [3][9]. However, if your doctor is testing for other mast cell mediators (like histamine or prostaglandins), these have extremely short half-lives and must be kept strictly chilled and frozen [13][14].
  • Request a Jug in Advance: Ask your doctor for a 24-hour urine collection jug to keep at home before you need it. If you are too sick to get to a lab safely, you will not be well enough to go pick up the jug.

What If You Miss the Window?

Even with the best preparation, you might miss the 1 to 4 hour window. If you cannot capture an acute tryptase spike, doctors often recommend a backup 24-hour urine collection [15][16]. This test measures other mast cell mediators, such as N-methylhistamine, leukotriene E4 (LTE4), and prostaglandins [17][9]. Because you already have the jug at home, you can begin the collection non-invasively without the stress of rushing to a lab [18].

The Diagnostic Importance: MCAS vs. MMCAS

If you are successfully able to document your flares, this tryptase history gives your care team crucial information to categorize your condition. It helps distinguish whether your symptoms are Idiopathic MCAS (iMCAS)—which involves hyperactive mast cells without an underlying genetic abnormality [8][19]—or if further investigation is needed.

A condition called Monoclonal Mast Cell Activation Syndrome (MMCAS) behaves similarly but stems from a clonal (abnormally mutating) population of mast cells, often identified by a KIT D816V mutation or a bone marrow biopsy [20][21]. Properly tracking your tryptase helps doctors decide if tests for MMCAS are necessary, or if you might be dealing with Systemic Mastocytosis (SM), a distinct and more pervasive clonal mast cell disease [22][23].

Common questions in this guide

Why do I only have 1 to 4 hours to get a tryptase test during a flare?
When mast cells release their contents during an MCAS flare, serum tryptase levels spike rapidly and peak within 1 to 2 hours. Because tryptase clears from the bloodstream quickly, waiting too long will result in falsely normal levels that miss the evidence of your flare.
What is a true baseline tryptase level?
A baseline tryptase level is a blood sample drawn when you are completely asymptomatic. This must typically be taken at least 24 to 48 hours after all flare symptoms have entirely resolved, allowing doctors to compare it against your flare levels.
How do doctors calculate if my tryptase rise indicates an MCAS flare?
Doctors use the 20% + 2 formula to determine if a flare has occurred. This means the tryptase level taken during your acute flare must be at least 20 percent higher than your baseline level, plus an additional 2 ng/mL.
What should I do if I experience anaphylaxis while trying to get my labs drawn?
If you experience signs of anaphylaxis, such as difficulty breathing or a sudden drop in blood pressure, emergency treatment always comes first. Never delay using epinephrine or calling emergency services just to get a lab test.
What happens if I miss the 1 to 4 hour window for my blood test?
If you cannot capture the tryptase spike in time, doctors often recommend a 24-hour urine collection as a backup. This test measures other mast cell mediators like N-methylhistamine and prostaglandins, and you can begin collecting it safely at home if you have a jug prepared.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you write me a standing lab order for a 'stat' acute serum tryptase and print any required handling instructions directly on the form?
  2. 2.When and how should I get my true baseline tryptase level drawn to ensure the 20% + 2 calculation is accurate?
  3. 3.Can I take home a 24-hour urine collection jug now, so I have it ready as a backup if I cannot make it to the lab during a flare?
  4. 4.Are you testing for other mediators like histamine or prostaglandins that require stricter freezing and handling protocols than tryptase?
  5. 5.Based on my symptoms and tryptase history, should we consider testing for the KIT D816V mutation or scheduling a bone marrow biopsy to rule out Monoclonal MCAS?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    How to diagnose mast cell activation syndrome: practical considerations.

    Romantowski J, Górska A, Lange M, et al.

    Polish archives of internal medicine 2020; (130(4)):317-323 doi:10.20452/pamw.15212.

    PMID: 32096778
  2. 2

    Mast cell activation syndrome-anesthetic challenges in two different clinical scenarios.

    Lide B, Mcguire S, Liu H, Chandler C

    Journal of biomedical research 2022; (36(6)):435-439 doi:10.7555/JBR.36.20220071.

    PMID: 35660674
  3. 3

    [Tryptase: A practical guide for the physician].

    Lobbes H, Reynaud Q, Mainbourg S, et al.

    La Revue de medecine interne 2020; (41(11)):748-755 doi:10.1016/j.revmed.2020.06.006.

    PMID: 32712042
  4. 4

    Mast Cell Activation Syndrome: Tools for Diagnosis and Differential Diagnosis.

    Weiler CR

    The journal of allergy and clinical immunology. In practice 2020; (8(2)):498-506 doi:10.1016/j.jaip.2019.08.022.

    PMID: 31470118
  5. 5

    Tryptase in type I hypersensitivity.

    Michel M, Klingebiel C, Vitte J

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2023; (130(2)):169-177 doi:10.1016/j.anai.2022.08.996.

    PMID: 36084866
  6. 6

    Tryptase: The Silent Witness of Past and Ongoing Systemic Events.

    Oštrić Pavlović I, Radović S, Krtinić D, et al.

    Medicina (Kaunas, Lithuania) 2024; (60(9)) doi:10.3390/medicina60091380.

    PMID: 39336421
  7. 7

    Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome.

    Valent P, Bonadonna P, Hartmann K, et al.

    International archives of allergy and immunology 2019; (180(1)):44-51 doi:10.1159/000501079.

    PMID: 31256161
  8. 8

    Idiopathic mast cell activation syndrome is more often suspected than diagnosed-A prospective real-life study.

    Buttgereit T, Gu S, Carneiro-Leão L, et al.

    Allergy 2022; (77(9)):2794-2802 doi:10.1111/all.15304.

    PMID: 35364617
  9. 9

    Nontryptase Urinary and Hematologic Biomarkers of Mast Cell Expansion and Mast Cell Activation: Status 2022.

    Butterfield JH

    The journal of allergy and clinical immunology. In practice 2022; (10(8)):1974-1984 doi:10.1016/j.jaip.2022.03.008.

    PMID: 35346887
  10. 10

    Diagnostic Value of Tryptase in Food Allergic Reactions: A Prospective Study of 160 Adult Peanut Challenges.

    Dua S, Dowey J, Foley L, et al.

    The journal of allergy and clinical immunology. In practice 2018; (6(5)):1692-1698.e1 doi:10.1016/j.jaip.2018.01.006.

    PMID: 29500041
  11. 11

    Utility of biomarkers in the postmortem diagnosis of fatal Anaphylaxis: A scoping review.

    Karthikeyan B, James RI, Daniel J, et al.

    Legal medicine (Tokyo, Japan) 2025; (74()):102610 doi:10.1016/j.legalmed.2025.102610.

    PMID: 40163933
  12. 12

    Diagnostic role of serum tryptase in anaphylactic deaths in forensic medicine: a systematic review and meta-analysis.

    Sun KJ, He JT, Huang HY, et al.

    Forensic science, medicine, and pathology 2018; (14(2)):209-215 doi:10.1007/s12024-018-9980-z.

    PMID: 29679215
  13. 13

    Massive release of the histamine-degrading enzyme diamine oxidase during severe anaphylaxis in mastocytosis patients.

    Boehm T, Reiter B, Ristl R, et al.

    Allergy 2019; (74(3)):583-593 doi:10.1111/all.13663.

    PMID: 30418682
  14. 14

    Biomarkers in Human Anaphylaxis: A Critical Appraisal of Current Evidence and Perspectives.

    Beck SC, Wilding T, Buka RJ, et al.

    Frontiers in immunology 2019; (10()):494 doi:10.3389/fimmu.2019.00494.

    PMID: 31024519
  15. 15

    Mast Cell Activation Syndrome and Gut Dysfunction: Diagnosis and Management.

    Hamilton MJ

    Current gastroenterology reports 2024; (26(4)):107-114 doi:10.1007/s11894-024-00924-w.

    PMID: 38353900
  16. 16

    Adult-onset mast cell activation syndrome following scombroid poisoning: a case report and review of the literature.

    Brock I, Eng N, Maitland A

    Journal of medical case reports 2021; (15(1)):620 doi:10.1186/s13256-021-03190-w.

    PMID: 34920756
  17. 17

    Urine Mast Cell Mediators in the Evaluation and Diagnosis of Mast Cell Activation Syndrome.

    Voelker D, Pongdee T

    Current allergy and asthma reports 2024; (24(2)):33-38 doi:10.1007/s11882-024-01128-y.

    PMID: 38236528
  18. 18

    Biomarkers in the diagnosis of mast cell activation.

    Voelker D, Pongdee T

    Current opinion in allergy and clinical immunology 2025; (25(1)):27-33 doi:10.1097/ACI.0000000000001046.

    PMID: 39745330
  19. 19

    Successful treatment of idiopathic mast cell activation syndrome with low-dose Omalizumab.

    Berry R, Hollingsworth P, Lucas M

    Clinical & translational immunology 2019; (8(10)):e01075 doi:10.1002/cti2.1075.

    PMID: 31576204
  20. 20

    A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis.

    Carter MC, Desai A, Komarow HD, et al.

    The Journal of allergy and clinical immunology 2018; (141(1)):180-188.e3 doi:10.1016/j.jaci.2017.05.036.

    PMID: 28629749
  21. 21

    Characterization of patients with clonal mast cells in the bone marrow with clinical significance not otherwise specified.

    Ballul T, Sabato V, Valent P, et al.

    EClinicalMedicine 2025; (80()):103043 doi:10.1016/j.eclinm.2024.103043.

    PMID: 39877259
  22. 22

    Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management.

    Castells M, Butterfield J

    The journal of allergy and clinical immunology. In practice 2019; (7(4)):1097-1106 doi:10.1016/j.jaip.2019.02.002.

    PMID: 30961835
  23. 23

    Omalizumab in the treatment of adult patients with mastocytosis: A systematic review.

    Jendoubi F, Gaudenzio N, Gallini A, et al.

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2020; (50(6)):654-661 doi:10.1111/cea.13592.

    PMID: 32107810

This page provides logistical information about obtaining lab work during an MCAS flare for educational purposes only. Always prioritize emergency medical care over blood tests if you experience signs of anaphylaxis.

Get notified when new evidence is published on Mast Cell Activation Syndrome (MCAS).

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.